Login
Enter your Progress In Mind Portugal username.
Enter the password that accompanies your username.

Request new password

Home

Progress in Mind Portugal

  • Topics
    • Depression
    • Migraine
    • Schizophrenia
  • Congress highlights
    • EAN 2022
    • AAN 2022
    • AHS 2022
    • AAN 2021
    • AHS 2021
    • IHC 2021
    • SIRS 2019
    • EPA 2019
    • EPA 2018
    • APA 2018
    • ECNP 2017
  • About
  • Podcasts
  • Newsletter signup

Search

Main navigation

  • Home
  • Lundbeck Therapeutic Area Australia
  • Progress in Mind Korea Focus Area
  • Progress in Mind Spain Focus Area
  • 전문가 칼럼
  • 찾아보기

Tools

  • 찾아보기
  • User Profile

User account menu

  • Log in
  • Reset your password
Powered by Drupal

The information on this site is exclusively intented for health care professionals.

Accept Decline

Progress in Mind Portugal

Your Psychiatry & Neurology Resource Center

COVID-19

Learn more

ECNP 21

Learn more
Medical education resource center

Do you want to learn more?

Medical education resource center
The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology.
Learn More

THINC®

Focus on cognitive symptoms in depression
See More

Recent News

  • All
  • 10 Oct, 2019

    Why is World Mental Health Day important?

  • 03 Oct, 2019

    What can clinicians do to mark World Mental Health Day?

  • Schizophrenia 12 Aug, 2019

    Video #6: Which patients are best suited for long-acting injectable antipsychotics?

  • Schizophrenia 11 Aug, 2019

    Video #5: Early intervention in schizophrenia is key for the long-term prognosis of the disease

  • Schizophrenia 10 Aug, 2019

    Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers

  • Depression, Schizophrenia 09 Aug, 2019

    Video #3: Shared decision-making and therapeutic alliance in schizophrenia

  • Schizophrenia 08 Aug, 2019

    Video #2: Patients at the center

  • Schizophrenia 07 Aug, 2019

    Video #1: Offering long-acting injectable antipsychotics to patients with schizophrenia

  • Schizophrenia 07 Jun, 2019 Read Time: 4 mins
    Congress highlights

    Early intervention for psychosis: Is it worth the investment?

    In a session at WFSBP, chaired by Professor Matcheri Keshavan, Harvard Medical School, Boston, MA,...
  • Bipolar 06 Jun, 2019 Read Time: 4 mins
    Satellite symposium

    Maintaining functioning in bipolar disorder: Treat early and prevent relapses

    Bipolar disorder (BD) should be considered a neuroprogressive disorder with poor outcomes1 said...

Pagination

  • First page «
  • Previous page ‹
  • …
  • Page 19
  • Page 20
  • Current page 21
  • Page 22
  • Page 23
  • …
  • Next page ›
  • Last page »

Most Popular

Progress in Mind Portugal HCP Access verification required

To gain access, please provide details to verify you are a healthcare professional.

If you are not located in Portugal click here.

Continue to verification page Login with email

Brought to you by

 Lundbeck

© 2021

PROGRESS IN MIND PORTUGAL

Cookies

Condições de Utilização

subscribe newsletter

Sign up for newsletter

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue

By submitting this form you agree that your email is sent to a third party for validation.

Read the full terms and conditions here.